Launch By Menarini And Ipsen Of ADENURIC(R) (febuxostat) In France For The Treatment Of Chronic Hyperuricemia In Gout (Medical News Today)

Ipsen (Paris:IPN) (Euronext: FR0010259150; IPN), a global biotechnology specialty care group and Menarini, the first Italian pharmaceutical Group in the world with a significant pan-European presence, announced the launch of ADENURIC® (febuxostat) in France where they will co-promote the drug. Other launches by Menarini are planned shortly, notably in United Kingdom, Germany and Ireland

Continue reading here:
Launch By Menarini And Ipsen Of ADENURIC(R) (febuxostat) In France For The Treatment Of Chronic Hyperuricemia In Gout (Medical News Today)

Share and Enjoy:
  • Print
  • Digg
  • Mixx
  • Google Bookmarks
  • Reddit
  • StumbleUpon
  • Technorati
  • Twitter
  • Yahoo! Buzz
Reply now | Feed

Leave a Reply


XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Wp Logo Theme: Guangzhou
Home